期刊
JOURNAL OF NEUROIMMUNE PHARMACOLOGY
卷 8, 期 1, 页码 37-41出版社
SPRINGER
DOI: 10.1007/s11481-012-9394-8
关键词
Eicosapentaenoic acid (EPA); Tumor necrosis factor-alpha(TNF-alpha); Lipopolisacride(LPS); Nerveinjury; Omega-3 poly unsaturated fatty acids; Spinal cord
资金
- US National Institutes of Health [R01-DE17794, NS54932, NS67686]
- [PBLAP3-123417]
- [PA00P3-134165]
Accumulating evidence indicates that activation of spinal cord microglia plays an important role in the genesis of neuropathic pain. Resolvin E1 (E1) is derived from omega-3 polyunsaturated fatty acid and exhibits potent anti-inflammatory, pro-resolution, and anti-nociceptive effects. We further examined whether RvE1 could reduce neuropathic pain and modulate spinal cord microglial activation. Intrathecal pre-treatment of RvE1 (100 ng) daily for 3 days partially prevented the development of nerve injury-induced mechanical allodynia and up-regulation of IBA-1 (microglial marker) and TNF-alpha in the spinal cord dorsal horn. Furthermore, intrathecal post-treatment of RvE1 (100 ng), 3 weeks after nerve injury, transiently reduced mechanical allodynia and heat hyperalgesia. Finally, RvE1 blocked lipopolisaccharide-induced microgliosis and TNF-alpha release in primary micoglial cultures. Our data suggest that RvE1 may attenuate neuropathic pain via inhibiting microglial signaling. Targeting the anti-inflammatory and pro-resolution lipid mediators may offer new options for preventing and treating neuropathic pain.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据